NASDAQ:SUPN is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Take a closer look at SUPERNUS PHARMACEUTICALS INC (NASDAQ:SUPN), a remarkable value stock uncovered by our stock screener. NASDAQ:SUPN excels in fundamentals and maintains a very reasonable valuation. Let's break it down further.

Valuation Assessment of NASDAQ:SUPN

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:SUPN has achieved a 8 out of 10:

• Based on the Price/Earnings ratio, SUPN is valued cheaper than 84.46% of the companies in the same industry.
• SUPN is valuated rather cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
• SUPN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SUPN is cheaper than 84.46% of the companies in the same industry.
• SUPN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.15.
• SUPN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SUPN is cheaper than 87.05% of the companies in the same industry.
• Compared to the rest of the industry, the Price/Free Cash Flow ratio of SUPN indicates a rather cheap valuation: SUPN is cheaper than 87.05% of the companies listed in the same industry.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• The decent profitability rating of SUPN may justify a higher PE ratio.
• A more expensive valuation may be justified as SUPN's earnings are expected to grow with 27.03% in the coming years.

How do we evaluate the Profitability for NASDAQ:SUPN?

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:SUPN, the assigned 6 is a significant indicator of profitability:

• Looking at the Return On Assets, with a value of -1.19%, SUPN belongs to the top of the industry, outperforming 80.83% of the companies in the same industry.
• With an excellent Return On Equity value of -1.67%, SUPN belongs to the best of the industry, outperforming 81.87% of the companies in the same industry.
• SUPN has a better Return On Invested Capital (0.52%) than 76.68% of its industry peers.
• SUPN has a better Operating Margin (1.09%) than 77.20% of its industry peers.
• With an excellent Gross Margin value of 87.17%, SUPN belongs to the best of the industry, outperforming 89.64% of the companies in the same industry.

What does the Health looks like for NASDAQ:SUPN

Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:SUPN has achieved a 6 out of 10:

• An Altman-Z score of 3.49 indicates that SUPN is not in any danger for bankruptcy at the moment.
• Looking at the Altman-Z score, with a value of 3.49, SUPN is in the better half of the industry, outperforming 78.76% of the companies in the same industry.
• There is no outstanding debt for SUPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

ChartMill's Evaluation of Growth

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:SUPN, the assigned 5 reflects its growth potential:

• SUPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.93%, which is quite impressive.
• Measured over the past years, SUPN shows a quite strong growth in Revenue. The Revenue has been growing by 8.24% on average per year.
• SUPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.45% yearly.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

More Decent Value stocks can be found in our Decent Value screener.

Check the latest full fundamental report of SUPN for a complete fundamental analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.